KR20220042403A - 연골 재생 촉진용 조성물 - Google Patents

연골 재생 촉진용 조성물 Download PDF

Info

Publication number
KR20220042403A
KR20220042403A KR1020227006304A KR20227006304A KR20220042403A KR 20220042403 A KR20220042403 A KR 20220042403A KR 1020227006304 A KR1020227006304 A KR 1020227006304A KR 20227006304 A KR20227006304 A KR 20227006304A KR 20220042403 A KR20220042403 A KR 20220042403A
Authority
KR
South Korea
Prior art keywords
composition
cartilage regeneration
hydroxyl group
promoting
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227006304A
Other languages
English (en)
Korean (ko)
Inventor
유타 오츠카
아유타 후나키
Original Assignee
산토리 홀딩스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 산토리 홀딩스 가부시키가이샤 filed Critical 산토리 홀딩스 가부시키가이샤
Publication of KR20220042403A publication Critical patent/KR20220042403A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020227006304A 2019-08-02 2020-07-21 연골 재생 촉진용 조성물 Ceased KR20220042403A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019143144 2019-08-02
JPJP-P-2019-143144 2019-08-02
PCT/JP2020/028306 WO2021024801A1 (ja) 2019-08-02 2020-07-21 軟骨再生促進用組成物

Publications (1)

Publication Number Publication Date
KR20220042403A true KR20220042403A (ko) 2022-04-05

Family

ID=74503458

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227006304A Ceased KR20220042403A (ko) 2019-08-02 2020-07-21 연골 재생 촉진용 조성물

Country Status (9)

Country Link
EP (1) EP4008401A4 (https=)
JP (1) JP7457713B2 (https=)
KR (1) KR20220042403A (https=)
CN (1) CN114206330A (https=)
AU (1) AU2020324628A1 (https=)
CA (1) CA3147400A1 (https=)
PH (1) PH12022550260A1 (https=)
TW (1) TW202120078A (https=)
WO (1) WO2021024801A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7457353B2 (ja) * 2020-04-28 2024-03-28 学校法人北陸大学 軟骨細胞への分化促進剤、軟骨細胞の増殖促進剤および軟骨基質産生促進剤
US20240390407A1 (en) * 2021-09-17 2024-11-28 Hokuriku University Promoter for differentiation into cartilage cell, cartilage cell propagation promoter, and cartilage matrix production promoter
WO2025031857A1 (en) 2023-08-09 2025-02-13 Basf Se Fungicidal compositions comprising carboxamides
CN117736980B (zh) * 2024-02-20 2024-05-10 广东先康达生物科技有限公司 脂肪间充质干细胞转化成软骨细胞的诱导分化培养基及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017014164A (ja) 2015-07-02 2017-01-19 株式会社東洋新薬 関節機能改善組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
JP4592249B2 (ja) * 2001-11-30 2010-12-01 江崎グリコ株式会社 リウマチの症状改善用飲食品および医薬
KR100437274B1 (ko) * 2003-10-15 2004-06-24 주식회사 케이엠에스아이 연골재생제로서 아피제닌을 함유하는 골관절염 치료 조성물
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis
RU2521227C1 (ru) * 2013-03-28 2014-06-27 Общество С Ограниченной Ответственностью "Парафарм" Композиция для лечения и предупреждения остеоартрита, остеопороза и остеоартроза суставов
CA2913621A1 (en) * 2013-05-29 2014-12-04 Nestec S.A. Compositions for use in cartilage breakdown
EP3563855A1 (en) * 2013-10-14 2019-11-06 Société des Produits Nestlé S.A. Treatment or prevention of synovitis using anti-inflammatory phytonutrients
KR101794503B1 (ko) * 2016-03-24 2017-11-08 주식회사 티제이씨라이프 강글리오사이드 ｇｍ３를 함유하는 연골세포 분화 유도용 조성물 및 이의 이용
CN108938618B (zh) * 2018-06-25 2022-04-22 中国科学院动物研究所 延缓人间充质干细胞衰老的化合物及其应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017014164A (ja) 2015-07-02 2017-01-19 株式会社東洋新薬 関節機能改善組成物

Also Published As

Publication number Publication date
PH12022550260A1 (en) 2022-11-21
CN114206330A (zh) 2022-03-18
CA3147400A1 (en) 2021-02-11
WO2021024801A1 (ja) 2021-02-11
AU2020324628A1 (en) 2022-03-10
EP4008401A1 (en) 2022-06-08
JPWO2021024801A1 (https=) 2021-02-11
TW202120078A (zh) 2021-06-01
JP7457713B2 (ja) 2024-03-28
EP4008401A4 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
JP7457713B2 (ja) 軟骨再生促進用組成物
DK2628484T3 (en) Trombocytrige plasma compositions
JP2012176949A (ja) ビタミンｄ化合物の使用
KR100946822B1 (ko) 칼슘 함유 조직 강화제 및 그 용도
JP5271534B2 (ja) 筋萎縮抑制剤
JP4390428B2 (ja) 含カルシウム組織強化剤
JP3749978B2 (ja) 抗骨粗鬆症作用を発揮する骨形成増進組成物
WO2011008052A2 (ko) 콜포신 다로페이트를 포함하는 골 질환의 예방 또는 치료용 조성물
HK40068648A (zh) 软骨再生促进用组合物
KR101888955B1 (ko) 참나리 주정 추출물을 유효성분으로 함유하는 관절염의 예방, 개선 또는 치료용 조성물
JP4723320B2 (ja) 血中レプチン濃度上昇剤
JP7332489B2 (ja) ホスホジエステラーゼ３阻害用組成物及び血小板凝集抑制用組成物
KR20120045122A (ko) 관절염을 포함한 골 질환 예방 및 치료용 조성물
KR102320684B1 (ko) 칼슘 및 천연물 조합 나노복합소재의 골다공증의 예방 또는 치료 용도
KR20210066783A (ko) 도인 추출물을 포함하는 골절 예방, 개선 또는 치료용 조성물
US20090163579A1 (en) Novel use of nutraceutical compositions
NL2036563B1 (en) Pharmaceutical composition for treating alzheimer's disease and application thereof
KR102531782B1 (ko) 루토나린을 포함하는 골질환 예방 또는 치료용 조성물
KR101054961B1 (ko) 알파-토코페롤 숙신산을 유효성분으로 포함하는 골 대사성 질환 예방 및 치료용 조성물
TW202135835A (zh) 用於促進硫酸軟骨素合成之組成物
KR20250162751A (ko) Dock5 억제제 및 bmp를 포함하는 조골세포 분화 촉진용 조성물 및 이의 용도
WO2025084391A1 (ja) β－ＮＭＮ及びプロテオグリカン含有経口用組成物
KR20120045121A (ko) 골 질환 예방 및 치료용 조성물
TW202333660A (zh) 軟骨再生促進劑
KR20230008614A (ko) 보골지 추출물을 유효성분으로 함유하는 상아질 또는 치수조직 재생용 조성물 및 이의 용도

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601